AGE-DEPENDENT DIFFERENCES OF LPS-INDUCED BDNF AND iNOS IN RAT SUBSTANTIA NIGRA
- Authors: Zakoliukina Y.S.1, Chuchkov V.M.1, Sergeyeva T.N.1, Vezheyeva O.A.1, Sergeyev V.G.1,2
-
Affiliations:
- Udmurt State University
- Izhevsk State Medical Academy
- Issue: Vol 153, No 2 (2018)
- Pages: 7-13
- Section: Articles
- Submitted: 09.05.2023
- Published: 15.04.2018
- URL: https://j-morphology.com/1026-3543/article/view/398217
- DOI: https://doi.org/10.17816/morph.398217
- ID: 398217
Cite item
Abstract
Full Text
![Restricted Access](https://j-morphology.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Ye. S. Zakoliukina
Udmurt State University
Email: alena-immun@yandex.ru
Department of Physiology, Cell Biology and Biotechnology
V. M. Chuchkov
Udmurt State University
Email: chuchkov.vm@obr18.ru
Department of Physiology, Cell Biology and Biotechnology
T. N. Sergeyeva
Udmurt State University
Email: tnbio@ya.ru
Department of Physiology, Cell Biology and Biotechnology
O. A. Vezheyeva
Udmurt State University
Email: promo-olga@ya.ru
Department of Physiology, Cell Biology and Biotechnology
V. G. Sergeyev
Udmurt State University; Izhevsk State Medical Academy
Email: cellbio@yandex.ru
Department of Physiology, Cell Biology and Biotechnology; Educational and Research Laboratory
References
- Заколюкина Е. С., Тукмачева К. А., Сергеев В. Г. Дозозависимый эффект ЛПС-индуцированной экспрессии BDNF в черной субстанции мозга крыс // Вестн. Удмуртск. ун-та. Сер. Биология. Науки о Земле. 2017. Т. 27, вып. 1. С. 80-86.
- Сергеева Т. Н., Сергеев В. Г., Чучков В. М. Клеточные механизмы хронического нейровоспаления // Морфологические ведомости. 2014. № 4. С. 31-36.
- Cardile V., Pavone A., Gulino R. et al. Expression of brain-derived neurotrophic factor (BDNF) and inducible nitric oxide synthase (iNOS) in rat astrocyte cultures treated with Levetiracetam // Brain Res. 2003. Vol. 976, № 2. P. 227-233.
- Kettenmann H., Hanisch U. K., Noda M., Verkhratsky A. Physiology of microglia // Physiol. Rev. 2011. Vol. 91, № 2. P. 461-553.
- Liberatore G. T., Jackson-Lewis V., Vukosavic S. et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease // Nature Med. 1999. Vol. 5, № 12. P. 1403-1409.
- Madinier A., Bertrand N., Mossiat C. et al. Microglial involvement in neuroplastic changes following focal brain ischemia in rats // PLoS One. 2010. Vol. 4, № 12. P. 1-12.
- Murer M. G., Yan Q. Raisman-Vozari R. Brainderived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease // Progr. Neurobiol. 2001. Vol. 3. P. 71-124.
- Murphy S. Production of nitric oxide by glial cells: regulation and potential roles in the CNS // Glia. 2000. Vol. 29, № 1. P. 1-13.
- Porritt M. J., Batchelor P., Howells D. Inhibiting BDNF ex pres sion by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons // Exp. Neurol. 2005. Vol. 192. P. 226-234.
- Przedborski S., Ischiropoulos H. Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson’s disease // Antioxid. Redox. Signal. 2005. Vol. 7. P. 685-693.
- Sastre M., Richardson J. C., Gentleman S. M., Brooks D. J. In flammatory risk factors and pathologies associated with Alzheimer’s disease // Curr. Alzheimer Res. 2011. Vol. 8, № 2. P. 132-141.
- Takano K., Yamasaki H., Kawabe K., Moriyama M., Nakamura Y. Imipramine induces brain-derived neurotrophic factor mRNA expression in cultured astrocytes // J. Pharmacol. Sci. 2012. Vol. 120, № 3. P. 176-186.
- Takemoto T., Ishihara Y., Ishida A., Yamazaki T. Neuroprotection elicited by nerve growth factor and brain-derived neurotrophic factor released from astrocytes in response to methylmercury // Environ. Toxicol. Pharmacol. 2015. Vol. 40, № 1. P. 199-205.
- Tansey M. G., Goldberg M. S. Neuroinflammation in Parkinson’s disease: its role in neuronal death and implications for therapeutic intervention // Neurobiol Dis. 2010. Vol. 37, № 3. P. 510-518.
- Wu D. C., Teismann P., Tieu K. et al. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease // PNAS. 2003. Vol. 100, № 10. P. 6145-6150.
Supplementary files
![](/img/style/loading.gif)